分裂促進因子
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2023/09/03 14:04 UTC 版)
分裂促進因子（ぶんれつそくしんいんし、英: mitogen）は、細胞分裂（有糸分裂（mitosis））の開始を誘導する低分子量タンパク質などの物質である。有糸分裂促進因子、有糸分裂誘発因子、マイトジェンなどの名称で呼ばれることもある。分裂促進因子による有糸分裂の誘導はMitogenesisと呼ばれる。分裂促進因子は、分裂促進因子活性化プロテインキナーゼ（MAPK）が関与するシグナル伝達を開始し、有糸分裂を誘導する。
- ^ Böhmer, R. M.; Scharf, E.; Assoian, R. K. (1996-01). “Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1”. Molecular Biology of the Cell 7 (1): 101–111. doi:10.1091/mbc.7.1.101. ISSN 1059-1524. PMC 278616. PMID 8741843.
- ^ Foijer, Floris; Wolthuis, Rob M. F.; Doodeman, Valerie; Medema, René H.; te Riele, Hein (2005-12). “Mitogen requirement for cell cycle progression in the absence of pocket protein activity”. Cancer Cell 8 (6): 455–466. doi:10.1016/j.ccr.2005.10.021. ISSN 1535-6108. PMID 16338659.
- ^ Gemberling, Matthew; Karra, Ravi; Dickson, Amy L.; Poss, Kenneth D. (2015-04-01). “Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish”. eLife 4. doi:10.7554/eLife.05871. ISSN 2050-084X. PMC 4379493. PMID 25830562.
- ^ Leung, D. W.; Cachianes, G.; Kuang, W. J.; Goeddel, D. V.; Ferrara, N. (1989-12-08). “Vascular endothelial growth factor is a secreted angiogenic mitogen”. Science (New York, N.Y.) 246 (4935): 1306–1309. doi:10.1126/science.2479986. ISSN 0036-8075. PMID 2479986.
- ^ a b c d e f g Morgan, David Owen (2007). The cell cycle : principles of control. London: New Science Press. ISBN 978-0-19-920610-0. OCLC 70173205
- ^ Waterfield, M. D.; Scrace, G. T.; Whittle, N.; Stroobant, P.; Johnsson, A.; Wasteson, A.; Westermark, B.; Heldin, C. H. et al. (1983 Jul 7-13). “Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus”. Nature 304 (5921): 35–39. doi:10.1038/304035a0. ISSN 0028-0836. PMID 6306471.
- ^ Mitri, Zahi; Constantine, Tina; O'Regan, Ruth (2012). “The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy”. Chemotherapy Research and Practice 2012: 743193. doi:10.1155/2012/743193. ISSN 2090-2115. PMC 3539433. PMID 23320171.
- ^ Santen, Richard J.; Song, Robert Xinde; McPherson, Robert; Kumar, Rakesh; Adam, Liana; Jeng, Meei-Huey; Yue, Wei (2002-02). “The role of mitogen-activated protein (MAP) kinase in breast cancer”. The Journal of Steroid Biochemistry and Molecular Biology 80 (2): 239–256. doi:10.1016/s0960-0760(01)00189-3. ISSN 0960-0760. PMID 11897507.
- ^ Barret, James (1980). Basic Immunology and its Medical Application (2 ed.). St.Louis: The C.V. Mosby Company. pp. 52–3. ISBN 978-0-8016-0495-9
- ^ Assenmacher, Mario; Avraham, Hava Karsenty; Avraham, Shalom et al., eds. (2005), “Pokeweed Mitogen” (英語), Encyclopedic Reference of Immunotoxicology, Springer, pp. 509, doi:10.1007/3-540-27806-0_1183, ISBN 978-3-540-27806-1
- ^ Font-Nieves, M; Sans-Fons, MG (2012). “Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes”. Journal of Biological Chemistry 287 (9): 6454–68. doi:10.1074/jbc.M111.327874. PMC 3307308. PMID 22219191.
- ^ Casciani, V; Marinoni, E (2008). “Opposite effect of phorbol ester PMA on PTGS2 and PGDH mRNA expression in human chorion trophoblast cells”. Reproductive Sciences 15 (1): 40–50. doi:10.1177/1933719107309647. PMID 18212353.
[続きの解説]
「分裂促進因子」の続きの解説一覧
- 1 分裂促進因子とは
- 2 分裂促進因子の概要
- 3 他の利用
- 分裂促進因子のページへのリンク
